January 26th- From Ibrutinib to Zanubrutinib in Waldenström Macroglobulinemia: Is Switching Safe- and Does It Matter? – International Academy for Clinical Hematology (IACH)

Skip to content

Home
About
IACH Academy
IACH Library
aIACH
Contact
Register | Login

Home
About
IACH Academy
IACH Library
aIACH
Contact
Register | Login

January 26th- From Ibrutinib to Zanubrutinib in Waldenström Macroglobulinemia: Is Switching Safe- and Does It Matter?

Join our E-learning platform

The IACH, founded by an international group of physicians whose focus is to promote good clinical practice in the field of clinical hematology

Copyright © 2026 International Academy for Clinical Hematology (IACH)

Login

Username or Email Address

Password

Remember Me

Lost Your Password?

Register

Don't have an account? Register one!

Register an Account

Name(Required)

First Last

Email(Required)

Country(Required)

Institution

EBAH Membership Number

Profession(Required)

Specialty - Please select all that apply(Required)

Password

Enter Password Confirm Password

CAPTCHA